105 results
Page 2 of 6
20-F/A
ibxa6hs3
31 Mar 21
Annual report (foreign) (amended)
12:00am
20-F/A
EX-12.2
r98s2p
31 Mar 21
Annual report (foreign) (amended)
12:00am
20-F/A
EX-12.1
kb2p0z szr5za
31 Mar 21
Annual report (foreign) (amended)
12:00am
D
2dxkg7u
26 Feb 21
$385.85K in equity, sold $385.85K, 1 investor
12:00am
6-K
EX-99.5
n5mu7kuh06d
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
ub39h9
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.2
mou9hhtqg88yx9gm18
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.1
u8fhjr5qwnarqpub9hmx
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
D
7f2x1j
20 Aug 20
$118.18K in equity, sold $118.18K, 2 investors
10:53am
6-K
EX-99.1
kykrcu yv
3 Aug 20
Consolidated Financial Statements
12:00am
D
c7a6zcoshxw 6yrw
24 Jul 20
$447.06K in equity / options / securities to be acquired, sold $447.06K, 2 investors
4:47pm
6-K
EX-99.1
a0af677w nc6f4pupt
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
D
o9075ekbb 96zxevcs
4 Nov 19
$135.08K in equity, sold $135.08K, 1 investor
3:29pm
D
w0prmd38zu
13 Sep 19
$76.03K in equity / securities to be acquired, sold $76.03K, 1 investor
12:40pm